Document is current
Any future updates will be listed below
-
Authors
Gasoyan, Hamlet https://orcid.org/0000-0002-1627-9777
Alavi, Mohammad Hesam
Zajichek, Alexander
Casacchia, Nicholas J. https://orcid.org/0000-0003-2291-835X
Al Jabri, Abdullah https://orcid.org/0000-0001-7838-9261
Bena, James https://orcid.org/0000-0002-7592-0480
Feng, Xiaoxi
Wilson, Rickesha
Corcelles, Ricard
Butsch, W. Scott
Singh, Rishi P.
Das, Nikhil
Jeong, Hejin https://orcid.org/0009-0001-7903-0792
Mentias, Amgad
Tang, W. H. Wilson https://orcid.org/0000-0002-8335-735X
Burguera, Bartolome
Rosenthal, Raul J.
Nissen, Steven E. https://orcid.org/0000-0002-7231-6464
Rothberg, Michael B. https://orcid.org/0000-0002-2063-1876
Aminian, Ali https://orcid.org/0000-0001-5756-9917
- License Information
-
More Information
Article History
Received: 25 October 2024
Accepted: 15 July 2025
First Online: 16 September 2025
Competing interests
: W.S.B. has received honoraria and paid consultancy from Novo Nordisk, Abbott Nutrition, Medscape, Alfie Health and the Med Learning Group. R.P.S. reported receiving personal fees from Alcon, Apellis, Bausch + Lomb, EyePoint, Genentech, Iveric Bio, Regeneron, Regenxbio and ZEISS, and research grants from Janssen. W.H.W.T. received consulting fees from Sequana Medical, Cardiol Therapeutics, Genomics plc, Zehna Therapeutics, WhiteSwell, Boston Scientific, CardiaTec Biosciences, Intellia Therapeutics, Bristol Myers Squibb, Alleviant Medical, Alexion Pharmaceuticals, Salubris Biotherapeutics and BioCardia, and received honoraria from Springer, Belvoir Media Group and the American Board of Internal Medicine. B.B. received an honorarium from Novo Nordisk. R.J.R. reported receiving personal fee from Medtronic, Diagnostic Green, mediCAD and Dendrite Imaging, and serving as the CEO of Dendrite Imaging. S.E.N. received grants to perform clinical trials from AbbVie, AstraZeneca, Amgen, Bristol Myers Squibb, Eli Lilly, Esperion Therapeutics, Medtronic, MyoKardia, New Amsterdam Pharmaceuticals, Novartis and Silence Therapeutics. M.B.R. has a consulting relationship with the Blue Cross Blue Shield Association. A.A. received research grants from Medtronic and Ethicon, and serves as a consultant for Medtronic, Ethicon and Eli Lilly. The other authors declare no competing interests.
